A shadow market for unlicensed slimming medications is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.
Experimental Drug Gaining Popularity Via Social Media
Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are encouraged to contact these profiles privately for source information, while also receiving discount codes.
Thriving Trade on Social Networks
Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share comparison images, injection guides and assertions of rapid British shipping. Sellers market the substance there before directing buyers to WhatsApp for transactions.
Understanding The Experimental Drug
This medication is an investigational injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Medical Professionals Express Worries
Nevertheless, doctors and chemists have cautions that the sale of what is still an unapproved medication in the UK is worrisome and could result in individuals injecting substances of uncertain source.
Several professionals said the demand for the experimental drug could be linked to the rising cost of licensed slimming treatments such as Mounjaro.
Legal Position and Enforcement
Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for human use under the British medical regulations.
Several content creators try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still breach medicines, marketing, and consumer laws, risking fines, legal action or prison.
Service Response and Content Removal
Based on the social media company, the service has taken down violative material and prohibited related keywords and search suggestions. The organization said it was committed to maintaining the platform secure and investing in strengthening enforcement strategies.
Digital Trading Activities
Research also found groups with up to 9,000 members marketing retatrutide using Telegram's integrated search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, populated with photos of slimming results, positive testimonials and detailed instructions for preparing or administering at home.
Within moments of joining one group, a vendor shared contact information, where the majority of purchases occur. The vendor sent an instruction manual and guaranteed delivery within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about weight, health issues or previous experience.
Product Information and Pricing
Within these groups, posts display dark colored packages with Royal Mail labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20mg. When questioned how long a injector should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.
Service Moderation and Safety Measures
A representative for the messaging service said it regularly moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are administering substances they cannot confirm. Although the research behind retatrutide is sound, these digital products may not include what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With costs rising, patients are using social media. But fake injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.
Her team has already seen patients injured by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental product not yet authorized … may expose patients to possibly significant health risks”.
